Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

BMJ. 2020 Oct 8;371:m3841. doi: 10.1136/bmj.m3841.
No abstract available

MeSH terms

  • Costs and Cost Analysis
  • Drug Development / economics*
  • Drug Industry / economics
  • Drug Industry / legislation & jurisprudence
  • Drug and Narcotic Control*
  • Financial Management* / methods
  • Financial Management* / organization & administration
  • Financing, Government / organization & administration*
  • Health Services Accessibility* / economics
  • Health Services Accessibility* / organization & administration
  • Health Services Needs and Demand
  • Humans
  • Policy Making
  • Prescription Drugs / economics*
  • United States

Substances

  • Prescription Drugs